Sarepta Therapeutics, Inc.
SRPT
$20.22
$0.160.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.21% | -62.41% | -19.18% | -30.87% | -21.51% |
| Total Receivables | 55.41% | 72.76% | 48.69% | 45.65% | 46.83% |
| Inventory | 104.62% | 152.04% | 132.29% | 131.93% | 114.12% |
| Prepaid Expenses | 0.05% | -14.60% | 10.94% | 11.69% | 24.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -29.57% | -13.12% | 149.40% | 311.40% | 243.63% |
| Total Current Assets | -0.99% | -1.31% | 19.16% | 9.57% | 8.53% |
|
|
|||||
| Total Current Assets | -0.99% | -1.31% | 19.16% | 9.57% | 8.53% |
| Net Property, Plant & Equipment | 28.66% | 35.17% | 36.84% | 29.17% | 23.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 8.03% | -9.44% | -9.23% | 41.38% | 56.80% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -18.81% | 23.52% | -18.73% | -11.26% | 8.52% |
| Total Assets | 7.46% | 7.47% | 21.40% | 15.76% | 9.55% |
|
|
|||||
| Total Accounts Payable | 27.26% | 70.54% | 30.03% | 35.05% | -2.17% |
| Total Accrued Expenses | -0.56% | 14.44% | 22.10% | 6.90% | -6.01% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -90.41% | -89.35% | -87.42% | 506.56% | 539.32% |
| Total Finance Division Other Current Liabilities | 113.35% | 7.80% | 41.53% | 79.45% | 74.73% |
| Total Other Current Liabilities | 113.35% | 7.80% | 41.53% | 79.45% | 74.73% |
| Total Current Liabilities | 33.62% | -0.51% | 11.94% | 55.19% | 38.07% |
|
|
|||||
| Total Current Liabilities | 33.62% | -0.51% | 11.94% | 55.19% | 38.07% |
| Long-Term Debt | 0.41% | 0.41% | 0.41% | -8.15% | -8.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 49.32% | 46.65% | 36.54% | 26.16% | 11.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -87.22% | -1.94% | -21.74% | -28.62% | -27.03% |
| Total Liabilities | -1.05% | 2.63% | 1.26% | 1.43% | -1.56% |
|
|
|||||
| Common Stock & APIC | 6.61% | 7.99% | 8.19% | 6.32% | 5.55% |
| Retained Earnings | -1.32% | -5.63% | 5.29% | 2.71% | 1.06% |
| Treasury Stock & Other | -2,357.67% | 104.92% | -123.75% | 451.88% | 2.37% |
| Total Common Equity | 26.03% | 18.89% | 77.78% | 59.75% | 45.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 26.03% | 18.89% | 77.78% | 59.75% | 45.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.03% | 18.89% | 77.78% | 59.75% | 45.27% |
|
|
|||||